Archit Organosys (BOM:524640) Other Current Receivables: ₹293 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524640 Archit Organosys Ltd BOM:524640
64 GF Score
Price ₹63.58
GF Value ₹55.46
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Archit Organosys Other Current Receivables?

Archit Organosys BOM:524640 +1.40% 64 Other Current Receivables is ₹293 Mil as of Mar. 2026. GuruFocus rates BOM:524640 with a GF Score™ of 64/100 and a GF Value™ of ₹55.46 (Modestly Overvalued). The stock has 8 warning signs investors should review.

Archit Organosys's Other Current Receivables for the quarter that ended in Mar. 2026 was ₹293 Mil.

Archit Organosys's quarterly Other Current Receivables declined from Sep. 2025 (₹367.09 Mil) to Dec. 2025 (₹0.00 Mil) but then increased from Dec. 2025 (₹0.00 Mil) to Mar. 2026 (₹292.74 Mil).

Archit Organosys's annual Other Current Receivables increased from Mar. 2024 (₹102.52 Mil) to Mar. 2025 (₹329.42 Mil) but then declined from Mar. 2025 (₹329.42 Mil) to Mar. 2026 (₹292.74 Mil).

Archit Organosys Other Current Receivables Related Terms

Archit Organosys Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Archit Organosys's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Archit Organosys Other Current Receivables Chart

Archit Organosys Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 32.99 1.18 102.52 329.42 292.74

Archit Organosys Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 329.42 0.00 367.09 0.00 292.74
BOM:524640
64GF Score
Archit Organosys Ltd BOM:524640
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Archit Organosys Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of ₹293 Mil mean?
Archit Organosys (BOM:524640) has a Other Current Receivables of ₹293 Mil as of Mar. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Archit Organosys and its competitors.
Is Archit Organosys' Other Current Receivables too high?
Archit Organosys' current Other Current Receivables is ₹293 Mil. Overall, Archit Organosys has a GF Score™ of 64/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Archit Organosys' Other Current Receivables compare to DOW?
Archit Organosys' Other Current Receivables of ₹293 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Chemicals company?
A good Other Current Receivables depends on the Chemicals industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Archit Organosys and its competitors. Archit Organosys's current Other Current Receivables is ₹293 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Archit Organosys stock overvalued right now?
Based on GuruFocus' analysis, Archit Organosys (BOM:524640) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹55.46, compared to a current price of ₹63.58 — trading 14.6% above its estimated fair value. The current Other Current Receivables is ₹293 Mil. Archit Organosys' overall GF Score™ is 64/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Archit Organosys (BOM:524640), the current Other Current Receivables is ₹293 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Archit Organosys (BOM:524640) Overvalued in 2026?

Based on GuruFocus' analysis, Archit Organosys stock appears to be overvalued. The current stock price of ₹63.58 is trading 14.6% above its estimated GF Value™ of ₹55.46. GuruFocus considers Archit Organosys to be Modestly Overvalued.

Key valuation signals for BOM:524640:

  • Other Current Receivables: ₹293 Mil
  • GF Value™: ₹55.46 vs. price of ₹63.58 (14.6% above fair value)
  • GF Score™: 64/100 with 8 warning signs

No single metric tells the full story. See the BOM:524640 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Archit Organosys Business Description

Address S. G. Highway, 9th Floor, Venus Benecia, Near Pakwan Restaurant, Bodakdev, Ahmedabad, GJ, IND, 380054
Archit Organosys Ltd is mainly engaged in the manufacturing and selling of various chemical products, including alkali chemicals, inorganic chemicals, organic chemicals, pesticides and insecticides, dyes, and dyestuff. The company mainly manufactures and trades chemicals such as Monochloro Acetic Acid (MCA), Sodium Monochloro Acetate (SMCA), Chloroacetyl Chloride, and Trichloroacetyl Chloride (TCAC). It operates in a single segment identified as manufacturing and trading of dyes, chemicals, and pigments. Geographically, it derives the majority of its revenue from India and also exports products to other countries.
64GF Score

Get the complete analysis for BOM:524640

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹63.58
Price
₹55.46
GF Value